Literature DB >> 20885434

Prophylactic antiparasitic transgenesis for human parasitic disease?

Julius Lukeš1, Jayne Raper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20885434      PMCID： PMC2951570          DOI： 10.1038/mt.2010.193

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes.

Authors:  David Pérez-Morga; Benoit Vanhollebeke; Françoise Paturiaux-Hanocq; Derek P Nolan; Laurence Lins; Fabrice Homblé; Luc Vanhamme; Patricia Tebabi; Annette Pays; Philippe Poelvoorde; Alain Jacquet; Robert Brasseur; Etienne Pays
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

Review 2.  Kinetoplastids: related protozoan pathogens, different diseases.

Authors:  Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

3.  Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I.

Authors:  Benoit Vanhollebeke; Philippe Truc; Philippe Poelvoorde; Annette Pays; Prashant P Joshi; Ravindra Katti; Jean G Jannin; Etienne Pays
Journal:  N Engl J Med       Date:  2006-12-28       Impact factor: 91.245

Review 4.  Switching trypanosome coats: what's in the wardrobe?

Authors:  Jesse E Taylor; Gloria Rudenko
Journal:  Trends Genet       Date:  2006-08-14       Impact factor: 11.639

5.  Serum resistance-associated protein blocks lysosomal targeting of trypanosome lytic factor in Trypanosoma brucei.

Authors:  Monika W Oli; Laura F Cotlin; April M Shiflett; Stephen L Hajduk
Journal:  Eukaryot Cell       Date:  2006-01

6.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

Authors:  Salima Hacein-Bey-Abina; Françoise Le Deist; Frédérique Carlier; Cécile Bouneaud; Christophe Hue; Jean-Pierre De Villartay; Adrian J Thrasher; Nicolas Wulffraat; Ricardo Sorensen; Sophie Dupuis-Girod; Alain Fischer; E Graham Davies; Wietse Kuis; Lilly Leiva; Marina Cavazzana-Calvo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

7.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Authors:  Alessandro Aiuti; Federica Cattaneo; Stefania Galimberti; Ulrike Benninghoff; Barbara Cassani; Luciano Callegaro; Samantha Scaramuzza; Grazia Andolfi; Massimiliano Mirolo; Immacolata Brigida; Antonella Tabucchi; Filippo Carlucci; Martha Eibl; Memet Aker; Shimon Slavin; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Alina Ferster; Andrea Duppenthaler; Luigi Notarangelo; Uwe Wintergerst; Rebecca H Buckley; Marco Bregni; Sarah Marktel; Maria Grazia Valsecchi; Paolo Rossi; Fabio Ciceri; Roberto Miniero; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

8.  Safety and efficacy of gene transfer for Leber's congenital amaurosis.

Authors:  Albert M Maguire; Francesca Simonelli; Eric A Pierce; Edward N Pugh; Federico Mingozzi; Jeannette Bennicelli; Sandro Banfi; Kathleen A Marshall; Francesco Testa; Enrico M Surace; Settimio Rossi; Arkady Lyubarsky; Valder R Arruda; Barbara Konkle; Edwin Stone; Junwei Sun; Jonathan Jacobs; Lou Dell'Osso; Richard Hertle; Jian-xing Ma; T Michael Redmond; Xiaosong Zhu; Bernd Hauck; Olga Zelenaia; Kenneth S Shindler; Maureen G Maguire; J Fraser Wright; Nicholas J Volpe; Jennifer Wellman McDonnell; Alberto Auricchio; Katherine A High; Jean Bennett
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

9.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

10.  Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model.

Authors:  Maria Pilar Molina-Portela; Marie Samanovic; Jayne Raper
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307
View more
  4 in total

Review 1.  Trypanosome resistance to human innate immunity: targeting Achilles' heel.

Authors:  Natalie A Stephens; Rudo Kieft; Annette Macleod; Stephen L Hajduk
Journal:  Trends Parasitol       Date:  2012-10-08

Review 2.  The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.

Authors:  Saharon Rosset; Shay Tzur; Doron M Behar; Walter G Wasser; Karl Skorecki
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

3.  Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.

Authors:  Paul Capewell; Nicola J Veitch; C Michael R Turner; Jayne Raper; Matthew Berriman; Stephen L Hajduk; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

4.  A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.

Authors:  Anneli Cooper; Paul Capewell; Caroline Clucas; Nicola Veitch; William Weir; Russell Thomson; Jayne Raper; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2016-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.